Correlation Between Lexaria Bioscience and Immatics Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Lexaria Bioscience and Immatics Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lexaria Bioscience and Immatics Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lexaria Bioscience Corp and immatics biotechnologies GmbH, you can compare the effects of market volatilities on Lexaria Bioscience and Immatics Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lexaria Bioscience with a short position of Immatics Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lexaria Bioscience and Immatics Biotechnologies.
Diversification Opportunities for Lexaria Bioscience and Immatics Biotechnologies
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lexaria and Immatics is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Lexaria Bioscience Corp and immatics biotechnologies GmbH in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immatics Biotechnologies and Lexaria Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lexaria Bioscience Corp are associated (or correlated) with Immatics Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immatics Biotechnologies has no effect on the direction of Lexaria Bioscience i.e., Lexaria Bioscience and Immatics Biotechnologies go up and down completely randomly.
Pair Corralation between Lexaria Bioscience and Immatics Biotechnologies
Assuming the 90 days horizon Lexaria Bioscience Corp is expected to generate 0.9 times more return on investment than Immatics Biotechnologies. However, Lexaria Bioscience Corp is 1.11 times less risky than Immatics Biotechnologies. It trades about 0.11 of its potential returns per unit of risk. immatics biotechnologies GmbH is currently generating about -0.28 per unit of risk. If you would invest 70.00 in Lexaria Bioscience Corp on September 1, 2024 and sell it today you would earn a total of 10.00 from holding Lexaria Bioscience Corp or generate 14.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 90.0% |
| Values | Daily Returns |
Lexaria Bioscience Corp vs. immatics biotechnologies GmbH
Performance |
| Timeline |
| Lexaria Bioscience Corp |
| Immatics Biotechnologies |
Lexaria Bioscience and Immatics Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lexaria Bioscience and Immatics Biotechnologies
The main advantage of trading using opposite Lexaria Bioscience and Immatics Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lexaria Bioscience position performs unexpectedly, Immatics Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immatics Biotechnologies will offset losses from the drop in Immatics Biotechnologies' long position.| Lexaria Bioscience vs. Lexaria Bioscience Corp | Lexaria Bioscience vs. Lixte Biotechnology Holdings | Lexaria Bioscience vs. GeoVax Labs | Lexaria Bioscience vs. Reviva Pharmaceuticals Holdings |
| Immatics Biotechnologies vs. Tff Pharmaceuticals | Immatics Biotechnologies vs. Eliem Therapeutics | Immatics Biotechnologies vs. Inhibrx | Immatics Biotechnologies vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |